EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript March 5, 2025
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54.
Tessa Romero – JPMorgan:
Yigal Nochomovitz – Citigroup:
Yatin Suneja – Guggenheim:
Kambiz Yazdi – Jefferies:
Jennifer Kim – Cantor Fitzgerald:
Graig Suvannavejh – Mizuho Securities:
Colleen Kusy – Baird:
Debanjana Chatterjee – JonesTrading:
Gregory Harrison – Scotiabank:
Yale Jen –...
